Guest Editor(s)
-
- Prof. Simone Ferrero
Academic Unit of Obstetrics and Gynecology, Ospedale Policlinico San Martino, Genoa, Italy.
Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Genoa, Italy.
Website | E-mail
-
- Dr. Luigi Della Corte
- Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Naples, Italy.
E-mail
-
- Dr. Pierluigi Giampaolino
- Department of Public Health, University of Naples Federico II, Naples, Italy.
Website | E-mail
Special Issue Introduction
Uterine fibroids (UFs) are the most common benign solid tumors in the female reproductive tract, which can cause severe menstrual bleeding and may affect fertility. It seriously affects the quality of life, work efficiency and sex life. The current management strategies mainly involve surgical intervention, but the choice of treatment depends on the age of the patient and the desire to maintain fertility or avoid "radical" surgery. Hysteroscopy and ultrasound hysterography can be used to assess the characteristics of uterine fibroids. Hormone therapy has been widely used to treat symptoms caused by uterine fibroids. However, these treatments are not curative, and symptoms usually recur after the treatments stop. Alternatively, these diseases can be treated with minimally invasive surgical techniques.
Submission Deadline
31 May 2021